182 related articles for article (PubMed ID: 32966131)
1. "CO"ping With a Sticky Situation.
Jain K; Tyagi T; Hwa J
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2344-2345. PubMed ID: 32966131
[No Abstract] [Full Text] [Related]
2. Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD
Kaczara P; Sitek B; Przyborowski K; Kurpinska A; Kus K; Stojak M; Chlopicki S
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2376-2390. PubMed ID: 32787519
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide shifts energetic metabolism from glycolysis to oxidative phosphorylation in endothelial cells.
Kaczara P; Motterlini R; Kus K; Zakrzewska A; Abramov AY; Chlopicki S
FEBS Lett; 2016 Oct; 590(20):3469-3480. PubMed ID: 27670394
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of the lipid-soluble CORM-2 and the water-soluble CORM-3 and CORM-A1 on platelet adhesion: The role of arachidonic acid metabolism.
Adach W; Olas B
Thromb Res; 2020 Apr; 188():61-64. PubMed ID: 32070829
[No Abstract] [Full Text] [Related]
6. Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer.
Magierowska K; Korbut E; Hubalewska-Mazgaj M; Surmiak M; Chmura A; Bakalarz D; Buszewicz G; Wójcik D; Śliwowski Z; Ginter G; Gromowski T; Kwiecień S; Brzozowski T; Magierowski M
Free Radic Biol Med; 2019 Dec; 145():198-208. PubMed ID: 31568823
[TBL] [Abstract][Full Text] [Related]
7. The interrelationship between gasotransmitters and lead-induced renal toxicity in rats.
Abdel-Zaher AO; Abd-Ellatief RB; Aboulhagag NA; Farghaly HSM; Al-Wasei FMM
Toxicol Lett; 2019 Aug; 310():39-50. PubMed ID: 30980911
[TBL] [Abstract][Full Text] [Related]
8. Recent progress on anti-nociceptive effects of carbon monoxide releasing molecule-2 (CORM-2).
Khir NAM; Noh ASM; Long I; Zakaria R; Ismail CAN
Mol Cell Biochem; 2024 Mar; 479(3):539-552. PubMed ID: 37106243
[TBL] [Abstract][Full Text] [Related]
9. A comparison of multifunctional donors of carbon monoxide: Their anticoagulant, antioxidant, anti-aggregatory and cytotoxicity activities in an in vitro model.
Adach W; Olas B
Nitric Oxide; 2020 Apr; 97():20-26. PubMed ID: 32006712
[TBL] [Abstract][Full Text] [Related]
10. [Suppressive effect of exogenous carbon monoxide on abnormal platelet exocytosis and its molecular mechanism in sepsis].
Liu D; Xu X; Zhuang M; Song M; Qin W; Wang X; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):110-6. PubMed ID: 26911941
[TBL] [Abstract][Full Text] [Related]
11. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide-releasing molecule-3 (CORM-3; Ru(CO)3Cl(glycinate)) as a tool to study the concerted effects of carbon monoxide and nitric oxide on bacterial flavohemoglobin Hmp: applications and pitfalls.
Tinajero-Trejo M; Denby KJ; Sedelnikova SE; Hassoubah SA; Mann BE; Poole RK
J Biol Chem; 2014 Oct; 289(43):29471-82. PubMed ID: 25193663
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide inhibits the nuclear-cytoplasmic translocation of HMGB1 in an in vitro oxidative stress injury model of mouse renal tubular epithelial cells.
Jia Y; Wang L; Zhao GY; Wang ZQ; Chen S; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):791-795. PubMed ID: 27924516
[TBL] [Abstract][Full Text] [Related]
15. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle.
Taillé C; El-Benna J; Lanone S; Boczkowski J; Motterlini R
J Biol Chem; 2005 Jul; 280(27):25350-60. PubMed ID: 15863496
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis.
Lancel S; Hassoun SM; Favory R; Decoster B; Motterlini R; Neviere R
J Pharmacol Exp Ther; 2009 May; 329(2):641-8. PubMed ID: 19190234
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide released by CORM-A1 prevents yeast cell death via autophagy stimulation.
Figueiredo-Pereira C; Menezes R; Ferreira S; Santos CN; Vieira HLA
FEMS Yeast Res; 2019 Aug; 19(5):. PubMed ID: 31344236
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide alleviates ethanol-induced oxidative damage and inflammatory stress through activating p38 MAPK pathway.
Li Y; Gao C; Shi Y; Tang Y; Liu L; Xiong T; Du M; Xing M; Liu L; Yao P
Toxicol Appl Pharmacol; 2013 Nov; 273(1):53-8. PubMed ID: 23994557
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide regulates glycolysis-dependent NLRP3 inflammasome activation in macrophages.
Lee DW; Shin HY; Jeong JH; Han J; Ryu S; Nakahira K; Moon JS
Biochem Biophys Res Commun; 2017 Nov; 493(2):957-963. PubMed ID: 28942141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
